Price Performance
- Day's Low
- ₹268.23
- Day's High
- ₹284.45
₹ 277.64
- 52-w low
- ₹97.45
- 52-w high
- ₹284.45
277.64
- Day's open
₹269.2 - Previous close
₹268.049988 - VWAP
₹277.98 - Lower price band
₹222.11 - Upper price band
₹333.16
Today's Market Action
The last traded share price of Marksans Pharma Ltd was 277.64 up by 3.58% on the NSE. Its last traded stock price on BSE was 277.35 up by 3.45%. The total volume of shares on NSE and BSE combined was 5,147,342 shares. Its total combined turnover was Rs 143.08 crores.
Medium and Long Term Market Action
Marksans Pharma Ltd hit a 52-week high of 284.45 on 16-09-2024 and a 52-week low of 97.45 on 26-10-2023.
The stock price of Marksans Pharma Ltd is up by 30% over the last one month. It is up by 169.68% over the last one year. Don't forget to check the full stock price history in the table below.
Fundamentals
-
Market Cap (Cr): 12582
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About
Data not available.
FAQ's
What is Share Price of Marksans Pharma Ltd?
What is the Market Cap of Marksans Pharma Ltd?
What is PE Ratio of Marksans Pharma Ltd?
What is PB Ratio of Marksans Pharma Ltd?
What is the CAGR of Marksans Pharma Ltd?
How to Buy Marksans Pharma Ltd Share?
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
Pros
Momentum Strength
Above Average Sustainable RoE
Cons
Low Return on Capital Employed
Highly Cyclical Industry
Poor Working Capital Cycle
Negative Margin of Safety
Valuation Analysis
Margin of safety
(16/09/2024)
(16/09/2024)
82
100.00%
100.00% People are bullish about Marksans Pharma Ltd
0.00%
0.00 % People are bearish about Marksans Pharma Ltd